Needham & Co Downgrades EPIX Pharmaceuticals (EPIX) to Hold
EPIX Hot Sheet
Rating Summary:0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 1
Needham & Co downgrades EPIX Pharmaceuticals (Nasdaq: EPIX) from Buy to Hold.
EPIX Pharmaceuticals, Inc. (EPIX) is a biopharmaceutical company focused on discovering, developing and commercializing pharmaceutical products.
EPIX Pharmaceuticals, Inc. (EPIX) is a biopharmaceutical company focused on discovering, developing and commercializing pharmaceutical products.
You May Also Be Interested In
- UPDATE: UBS Downgrades Wisconsin Energy (WEC) to Neutral; Taking Some Off The Table
- Mizuho Securities Downgrades Dell (DELL) to Neutral
- UPDATE: UBS Downgrades Avon Products (AVP) to Sell; Still Cautious Even After Sell Off
Create E-mail Alert Related Categories
DowngradesRelated Entities
Needham & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
